To access this element change to forms mode OFF
Grant Award View - GA29817
Role of neuroinflammation and neurotransmitter systems in the improved...
GA ID:
GA29817
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$712,518.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Role of neuroinflammation and neurotransmitter systems in the improved cognition induced by estrogen receptor modulation
Purpose:
Cognitive problems prevent people with schizophrenia from studying, working and forming social connections. There are no clinical treatments for cognitive problems. We have found that the estrogen receptor modulator, raloxifene, improves cognition in people with schizophrenia. Determining the molecular mechanisms that contribute to this improvement in cognition will provide molecular targets for the development of more effective therapeutics to enhance cognition and prevent cognitive decline.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1160399
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA